Immunohistochemical staining
Immunohistochemical staining is a biological therapy with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinicopathological Value of p16 Expression in Colorectal Carcinoma
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
Clinical Trials (11)
Clinicopathological Value of p16 Expression in Colorectal Carcinoma
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
Significance of Cortactin Expression in Colorectal Adenocarcinomas
Immunology Dysregulation in Lymphadenitis Tuberculosis : An Observational Study Using Patient' Block Paraffins 2019 Until 2021
PDL1 in Ovarian High Grade Serous Carcinoma
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
Does Immunotherapy Have a Role in the Management of Endometriosis?
Inflammation and Steatosis: the Role of Alpha-defensin
All 11 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 11